Form 8-K - Current report:
SEC Accession No. 0000950170-21-000394
Filing Date
2021-06-25
Accepted
2021-06-25 16:02:03
Documents
12
Period of Report
2021-06-24
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K flxn-20210624.htm   iXBRL 8-K 66012
  Complete submission text file 0000950170-21-000394.txt   184005

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flxn-20210624.xsd EX-101.SCH 2462
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flxn-20210624_pre.xml EX-101.PRE 10001
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flxn-20210624_lab.xml EX-101.LAB 13496
5 EXTRACTED XBRL INSTANCE DOCUMENT flxn-20210624_htm.xml XML 4710
Mailing Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803
Business Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803 (781) 305-7777
Flexion Therapeutics Inc (Filer) CIK: 0001419600 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36287 | Film No.: 211047655
SIC: 2834 Pharmaceutical Preparations